4,4-Dimethyl-14alpha-formyl-5alpha-cholesta-8-en-3beta-ol (BioCAD00000025181)
{$topic}
Metabolite Card
Formula: C30H50O2 (442.3811)
SMILES: CC(C)CCCC(C)C1CC[C@@]2(C=O)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)C1CC3
Synonyms [en]
4,4-Dimethyl-14alpha-formyl-5alpha-cholesta-8-en-3beta-ol; 4,4-Dimethyl-14α-formyl-5α-cholesta-8-en-3β-ol; 4,4-dimethyl-14alpha-formyl-5alpha-cholest-8-en-3beta-ol; 4,4-Dimethyl-14alpha-formyl-5alpha-cholesta-8-en-3-beta-ol; Lanosten-3-ol-32-al; 4,4-Dimethyl-14alpha-formyl-5alpha-cholesta-8-en-3 beta-ol
Last reviewed on 2024-06-28.
Cite this Page
4,4-Dimethyl-14alpha-formyl-5alpha-cholesta-8-en-3beta-ol. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000025181). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
4, 4-Dimethyl-14alpha-formyl-5alpha-cholesta-8-en-3beta-ol is a 3-beta-hydroxysterol that is an intermediate in cholesterol biosynthesis. It is a substrate for lanosterol 14alpha-demethylase (CYP51A1) and can be generated from the enzymatic oxidation of 4,4-dimethyl-14alpha-hydroxymethyl-5alpha-cholesta-8-en-3beta-ol. The sequence of reactions and the types of intermediates in cholesterol biosynthesis may vary. Alternate routes exist because reduction of the carbon 24,25 double bond on the hydrocarbon side chain of the sterol ring structure by sterol delta24-reductase can occur at multiple points in the pathway, giving rise to different intermediates. These intermediates, with or without a double bond in the hydrocarbon side chain, can serve as substrates for the other enzymes in the pathway.
DBLinks
- CAS Registry Number: 59200-40-7
- PubChem CID: 25203343
- ChEBI: 87060
- HMDB: HMDB0012159
- LipidMaps: LMST01010223
- KEGG:
- BioCyc: CPD-8608
- NCBI MeSH:
- Wikipedia:
Other DBLinks
- CAS Registry Number: 59200-40-7
- PubChem: 25203343
- ChEBI: ChEBI:87060
- HMDB: HMDB0012159
- LipidMaps: LMST01010223
- BioCyc: CPD-8608
Class / Ontology
- WishartLab ClassyFire: [Triterpenoids] Triterpenoids
- ChEBI: [CHEBI:87060] 3beta-hydroxylanost-8-en-32-al
| ID | EC Number | Name |
|---|---|---|
| Rhea:RHEA:75084 | 32-oxo-24,25-dihydrolanosterol + reduced [NADPH—hemoprotein reductase] + O2 => 4,4-dimethyl-8,14-cholestadien-3β-ol + formate + oxidized [NADPH—hemoprotein reductase] + H2O + 2 H+ | |
| Rhea:RHEA:75085 | 4,4-dimethyl-8,14-cholestadien-3β-ol + formate + oxidized [NADPH—hemoprotein reductase] + H2O + 2 H+ => 32-oxo-24,25-dihydrolanosterol + reduced [NADPH—hemoprotein reductase] + O2 | |
| Rhea:RHEA:75086 | 32-oxo-24,25-dihydrolanosterol + reduced [NADPH—hemoprotein reductase] + O2 <=> 4,4-dimethyl-8,14-cholestadien-3β-ol + formate + oxidized [NADPH—hemoprotein reductase] + H2O + 2 H+ | |
| Rhea:RHEA:75088 | 32-hydroxy-24,25-dihydrolanosterol + reduced [NADPH—hemoprotein reductase] + O2 => 32-oxo-24,25-dihydrolanosterol + oxidized [NADPH—hemoprotein reductase] + 2 H2O + H+ | |
| Rhea:RHEA:75089 | 32-oxo-24,25-dihydrolanosterol + oxidized [NADPH—hemoprotein reductase] + 2 H2O + H+ => 32-hydroxy-24,25-dihydrolanosterol + reduced [NADPH—hemoprotein reductase] + O2 | |
| Rhea:RHEA:75090 | 32-hydroxy-24,25-dihydrolanosterol + reduced [NADPH—hemoprotein reductase] + O2 <=> 32-oxo-24,25-dihydrolanosterol + oxidized [NADPH—hemoprotein reductase] + 2 H2O + H+ | |
| BioCyc:RXN66-12 | 4,4-dimethyl-14α-hydroxymethyl-5α-cholesta-8-en-3β-ol 14-dehydrogenase | |
| BioCyc:RXN66-13 | 4,4-dimethyl-14α-formyl-5α-cholesta-8-en-3β-ol deformylase |
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| BioCyc:MOUSE_PWY66-3 | cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
| BioCyc:THAPS_PWY66-5 | superpathway of cholesterol biosynthesis |
| BioCyc:SMAN_PWY66-5 | superpathway of cholesterol biosynthesis |
| BioCyc:PCHR_PWY66-3 | cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
| BioCyc:THAPS_PWY66-3 | cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
| BioCyc:SMAN_PWY66-3 | cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |